Brain Tumour Drug Development

Provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.

Key Features

Overcomes the blood-brain barrier using advanced delivery methods

Improves drug penetration & specificity with nano and polymer-based systems

Explores new therapies through immunotherapy, gene therapy, and personalised medicine

Builds preclinical models & identifies biomarkers to support clinical success

Designs regulatory-aligned clinical trial strategies for faster translation